With our clinical trial matching software and our partners’ condition expertise, we’re creating curated searches with a patient-centric approach.

Antidote is the Corporate Honoree at the MSAA’s 10th annual Improving Lives Benefit on May 15.

This empowers users to search for type 1 diabetes trials in Spanish, a significant step to improve diversity, equity, and inclusion in diabetes research.

Antidote and XpertPatient have partnered to provide newly-diagnosed cancer patients with more resources for finding clinical trials.

Antidote has received the Silver Award from Ecovadis for two years in a row due to our commitment to ESG initiatives.

Patients Rising is an organization that is partnering with Antidote to improve health literacy, patient-centricity, and clinical trial participation.

In our latest partner profile, we're featuring Beyond T1D to discuss their recent rebrand from JDRF and how they serve the type 1 diabetes community.

In this interview, we speak with a multiple sclerosis care partner about the process of living with MS.

Ira and Sandy Asherman have been married for 40 years, but since Sandy’s Alzheimer’s diagnosis, Ira has stepped into the critical role of caregiver.

In this overview of endometrial cancer, we are sharing some key things to note about the condition for those who have been diagnosed.

In the latest Antidote whitepaper, we're sharing insights about Alzheimer's patients and caregivers that can be used to inform clinical trial recruitment.

Get the perspective of Carla Greenbaum, M.D., a leading investigator at Benaroya Research Institute who studies the natural history of type 1 diabetes.